CannabisNewsWire
Editorial Coverage: Skepticism has been squashed and all
apprehension eliminated. There’s no longer any question about
either the viability or the profitability of the newly respected
cannabis sector. Huge money has already been made in the nascent
industry, and the only real question left is: where’s the next
super nova?
Quarter-over-quarter sales growth is one of the indicators used
to target explosive upside potential. Similar growth patterns were
exhibited by many of the cannabis behemoths prior to parabolic
price increases. In what may be an equally telling indicator,
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF
Profile) revenues have now increased 11 consecutive
quarters, quarter on quarter, ever since the company started
selling its hemp-based CBD products. Similar quarterly sales spikes
and strategic acquisitions foreshadowed dramatic price increases in
some of the largest names in the cannabis universe. Last October
Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF)
soared 60% in one week when the company announced a deal to buy
PharmCann. Florida-based Trulieve Cannabis Corp. (OTC:
TCNNF) (CSE: TRUL) went public last September through a
reverse merger in Canada and soared 200% after a strong 2018 Q2.
Already up big on Canadian exchanges, Cronos Group Inc.
(NASDAQ: CRON) (TSX: CRON) became the first pure-play
marijuana stock to list on NASDAQ around $7 and just bounced off
$23 a share. Last year, Tilray Inc. (NASDAQ: TLRY)
became the first cannabis company to IPO on the NASDAQ at $17 per
share and by September skyrocketed to $300. Despite price surges
and fluctuations in the big cannabis names, there’s bound to be
more money made in the sector; the run is far from over.
- Cannabis run is far from over, new winners emerging
- Branding, marketing and retail reach signals of success
- Quarter-over-quarter revenue increase helps identify future
potential
To view an infographic of this editorial, click here.
Good Times Have Just Begun
Legal cannabis is a recent global phenomenon, and the emergent
market appears to be nowhere near reaching its potential. The
worldwide legal marijuana market, valued at just $9.3 billion in
2016, is expected to blow past $146 billion
within the next six years.
According to a United Nations report, cannabis is the most
widely consumed drug on the planet. Approximately 270 million
global consumers use cannabis, equivalent to about 4% of the
world’s population and a mere pittance in market penetration. As
marijuana muscles into the mainstream, usage among all age groups
is on the upswing. However, among the most coveted
18-to-34-year-old demographic, there’s an explosion of acceptance
as they mature in a world where cannabis is common.
Millennials are about three times and Gen Z about four times
more likely
to use cannabis than aging Boomers. Forward-leaning cannabis
companies are full throttle in product and brand development to
corral this coveted demographic and capture market share, now and
for decades to come. As public perceptions change and legalization
expands, the number of users is certain to skyrocket in an
essentially untapped market. A global transition is underway, and
the good times for cannabis have just begun. Growth trajectory is
virtually vertical, presenting a once-in-a-generation investment
opportunity.
Retail Reach
Founded in 2012 as a private company, Wildflower
Brands Inc. (CSE: SUN) (OTCQB: WLDFF) went public in
2014 and has been on a tear ever since. Wildflower is an integrated
health-and-wellness company creating distinct brands that
incorporate the synergistic effects of plants and their extracts.
The company’s latest quarterly sales set records, up 78% over
the previous quarter, validating corporate strategy, the popularity
of its products, and the continued expansion of market share.
Intent on supercharging revenue and earnings even further,
Wildflower is about to finalize the acquisition of a preeminent
cannabis retailer in Vancouver that also owns multiple cannabis
licenses.
Wildflower’s latest press
release is further evidence of the company’s rapid growth and
global reach. The company reported third-quarter sales were up by
78% over the second quarter, the 11th consecutive quarter of
revenue growth, since Wildflower Brands began selling products. On
top of these stellar results the company is further expanding its
retail footprint and product distribution with the accretive
acquisition of Vancouver-based City Cannabis Corp.
City Cannabis is a premier cannabis retailer holding two of the
three City of Vancouver licenses to sell cannabis and os the only
company with multiple licenses in British Columbia. With margins of
50%, City Cannabis had revenues of $1.8 million for the reporting
period that began with the opening of its two stores in early
January. The combined quarterly revenues of Wildflower Brands and
City Cannabis equates to an impressive $4.3 million. Wildflower
expects to close on the City Cannabis deal before the end of June,
and the acquisition will immediately be accretive to Wildflower’s
earnings upon closing.
Bringing City Cannabis and Wildflower together will result in
revenue operations in three U.S. states and two Canadian provinces
with a combined North American target market of more than 75
million people. The positive net income generated by City Cannabis
comes from just two operating properties, even though the company
holds an additional seven leases at various stages of permitting
approvals.
Commenting on the financials, Wildflower CEO William MacLean
stated, “We are pleased with the financial results of both
Wildflower and City Cannabis. Sales through every Wildflower
distribution channel are up, and sales at City’s licensed retail
outlets continue to grow month over month. The positive net income
is particularly impressive with City Cannabis carrying a total of
nine leases, which are at various stages of the permitting
process.”
Grow, Grow, Grow
Already an established presence in California, Wildflower owns
14 cannabis licenses for recreational and medical cannabis
cultivation, manufacturing, retail distribution and delivery. The
company’s expansion into Canada with the acquisition of City
Cannabis bolsters Wildflower’s global growth strategy, which is
includes strategic distribution deals already in place in the
European
Union and South
Africa. In addition to capturing revenues from retail
operations, the City acquisition gives Wildflower another channel
to market its enormously popular products and launch into the
over-the-counter market with its CBD formulations and
accessories.
Wildflower continues to capture ever-greater market share with
innovation, retail expansion and a growing family of popular
brands. The company’s strategic partnerships, acquisitions and
organic growth are all bolstered by its marketing genius to lock in
more loyal consumers. Grabbing national and celebrity attention,
Wildflower used ingenious product placement during the 2019 Oscars
by including its CBD+ Healing Stick in each of the gift bags of the
stars.
The company has also employed an innovative pop-up store
approach in SoHo, New York, to introduce Wildflower Wellness
products. Wildflower identified a compatible high-profile retail
venue and struck a deal with the outlet, then marketed its products
in the upscale establishment for a limited time period, raising
market uptake and visibility.
Big Names
Medmen Enterprises Inc. (CSE: MMEN) (OTCQX:
MMNFF) is a cannabis retailer with operations across the
United States and flagship stores in Los Angeles, Las Vegas and New
York. Company objectives are to capitalize on first-mover advantage
by opening stores in top markets and building brand awareness and
customer acquisition. The company is also intent on expanding
retail footprint and creating an omnichannel consumer
experience.
Trulieve Cannabis Corp (OTC: TCNNF) (CSE: TRUL)
is a vertically integrated, seed-to-sale company and is the first
and largest fully licensed medical-cannabis company in Florida.
Trulieve cultivates and produces all of its products in-house and
distributes those products to Trulieve-branded stores
(dispensaries) throughout the state, as well as directly to
patients via home delivery. Trulieve also operates in California,
Massachusetts and Connecticut.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is
a global cannabinoid company with international production and
distribution across five continents. Cronos Group is committed to
building disruptive intellectual property by advancing cannabis
research, technology and product development. The company is
committed to responsibly elevate the consumer experience and is
building an iconic brand portfolio.
Tilray Inc. (NASDAQ: TLRY) is a global pioneer
in the research, cultivation, production and distribution of
cannabis and cannabinoids. The company currently serves tens of
thousands of patients and consumers in 12 countries spanning 5
continents. Tilray was the first licensed producer of medical
cannabis in the world to have its facility Good Manufacturing
Practices (GMP) certified in accordance with European Medicine
Agency (EMA) standards.
The cannabis markets have already produced some amazing profits,
but all indications are the industry is only at the beginning of an
amazing ascent. There’s little doubt that a plethora of new winners
will be created in the burgeoning sector. When searching for the
next super nova, Wildflower Brands is certainly one to watch.
For more information on Wildflower Brands, visit Wildflower
Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Wildflower Brands (CE) (USOTC:WLDFF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Wildflower Brands (CE) (USOTC:WLDFF)
Historical Stock Chart
From Dec 2023 to Dec 2024
